Vol 8, No 3 (June 23, 2017): Journal of Gastrointestinal Oncology (Novel Biologics In Era of Precision Medicine)1

Editorial

Entering the molecular era of gastrointestinal oncology: current updates and challenges
Andrea Wang-Gillam, Kian-Huat Lim
Journal of Gastrointestinal Oncology  
2017;
8
(3)
:377-378
.

Review Article

Molecular landscape and sub-classification of gastrointestinal cancers: a review of literature
Bita Fakhri, Kian-Huat Lim
Journal of Gastrointestinal Oncology  
2017;
8
(3)
:379-386
.
Personalized and precision medicine: integrating genomics into treatment decisions in gastrointestinal malignancies
Trang H. Au, Kai Wang, David Stenehjem, Ignacio Garrido-Laguna
Journal of Gastrointestinal Oncology  
2017;
8
(3)
:387-404
.
Predictive and prognostic biomarkers in personalized gastrointestinal cancer treatment
Helena Verdaguer, Tamara Saurí, Teresa Macarulla
Journal of Gastrointestinal Oncology  
2017;
8
(3)
:405-417
.
Biologic therapy in esophageal and gastric malignancies: current therapies and future directions
Pamela Samson, A. Craig Lockhart
Journal of Gastrointestinal Oncology  
2017;
8
(3)
:418-429
.
Current biologics for treatment of biliary tract cancers
Diana Y. Zhao, Kian-Huat Lim
Journal of Gastrointestinal Oncology  
2017;
8
(3)
:430-440
.
Shifting paradigm of developing biologics for the treatment of pancreatic adenocarcinoma
Ying Zeng, Agnieszka A. Rucki, Xu Che, Lei Zheng
Journal of Gastrointestinal Oncology  
2017;
8
(3)
:441-448
.
Biologics in bowel cancer
Marcus S. Noel
Journal of Gastrointestinal Oncology  
2017;
8
(3)
:449-456
.
Biologics in gastrointestinal and pancreatic neuroendocrine tumors
Iris H. Liu, Pamela L. Kunz
Journal of Gastrointestinal Oncology  
2017;
8
(3)
:457-465
.
Gastrointestinal stromal tumors (GISTs): point mutations matter in management, a review
Peter J. Oppelt, Angela C. Hirbe, Brian A. Van Tine
Journal of Gastrointestinal Oncology  
2017;
8
(3)
:466-473
.
Immunotherapy in gastrointestinal cancers
Patrick Grierson, Kian-Huat Lim, Manik Amin
Journal of Gastrointestinal Oncology  
2017;
8
(3)
:474-484
.
Biological agents in gastrointestinal cancers: adverse effects and their management
Nivedita Arora, Arjun Gupta, Preet Paul Singh
Journal of Gastrointestinal Oncology  
2017;
8
(3)
:485-498
.
Primary and acquired resistance to biologic therapies in gastrointestinal cancers
Sam J. Lubner, Nataliya V. Uboha, Dustin A. Deming
Journal of Gastrointestinal Oncology  
2017;
8
(3)
:499-512
.
Cost-effectiveness of precision medicine in gastrointestinal stromal tumor and gastric adenocarcinoma
Simon B. Zeichner, Daniel A. Goldstein, Christine Kohn, Christopher R. Flowers
Journal of Gastrointestinal Oncology  
2017;
8
(3)
:513-523
.
Promising therapeutics of gastrointestinal cancers in clinical trials
Lingling Du, Zheng Che, Andrea Wang-Gillam
Journal of Gastrointestinal Oncology  
2017;
8
(3)
:524-533
.

Systematic Reviews and Meta-analysis

Systematic review and a meta-analysis of hospital and surgeon volume/outcome relationships in colorectal cancer surgery
Ya Ruth Huo, Kevin Phan, David L. Morris, Winston Liauw
Journal of Gastrointestinal Oncology  
2017;
8
(3)
:534-546
.

Original Article

Bone marrow tolerance during postoperative chemotherapy in colorectal carcinomas
Neil B. Newman, Rebecca A. Moss, Nell Maloney-Patel, Kristen Donohue, Teresa V. Brown, Michael J. Nissenblatt, Shou-En Lu, Salma K. Jabbour
Journal of Gastrointestinal Oncology  
2017;
8
(3)
:547-555
.
Gemcitabine/nab-paclitaxel as second-line therapy following FOLFIRINOX in metastatic/advanced pancreatic cancer—retrospective analysis of response
Khanh T. Nguyen, Aparna Kalyan, H. Scott Beasley, Aatur D. Singhi, Weijing Sun, Herbert J. Zeh, Daniel Normolle, Nathan Bahary
Journal of Gastrointestinal Oncology  
2017;
8
(3)
:556-565
.
Comparison of efficacy and toxicity of FOLFIRINOX and gemcitabine with nab-paclitaxel in unresectable pancreatic cancer
Tetsuhito Muranaka, Masaki Kuwatani, Yoshito Komatsu, Kentaro Sawada, Hiroshi Nakatsumi, Yasuyuki Kawamoto, Satoshi Yuki, Yoshimasa Kubota, Kimitoshi Kubo, Shuhei Kawahata, Kazumichi Kawakubo, Hiroshi Kawakami, Naoya Sakamoto
Journal of Gastrointestinal Oncology  
2017;
8
(3)
:566-571
.
Overall and disease-free survival in patients treated with CRS + HIPEC with cisplatin and paclitaxel for gastric cancer with peritoneal carcinomatosis
Paola Fugazzola, Federico Coccolini, Giulia Montori, Marco Ceresoli, Paolo Baggi, Antonio Costanzo, Matteo Tomasoni, Francesco Gregis, Silvia Nozza, Luca Ansaloni
Journal of Gastrointestinal Oncology  
2017;
8
(3)
:572-582
.
Effect of Helicobacter pylori infection on outcomes in resected gastric and gastroesophageal junction cancer
Jennifer M. Kolb, Umut Ozbek, Noam Harpaz, Randall F. Holcombe, Celina Ang
Journal of Gastrointestinal Oncology  
2017;
8
(3)
:583-588
.
Sarcopenia related to neoadjuvant chemotherapy and perioperative outcomes in resected gastric cancer: a multi-institutional analysis
Katelin A. Mirkin, Franklyn E. Luke, Alexandra Gangi, Jose M. Pimiento, Daniel Jeong, Christopher S. Hollenbeak, Joyce Wong
Journal of Gastrointestinal Oncology  
2017;
8
(3)
:589-595
.

Educational Case Series of the Memorial Sloan Kettering Cancer Center2

An elderly man with remote history of metastatic melanoma now with localized pancreas cancer and new liver masses
Neil Vasan, Maria Ignez Braghiroli, Alexander N. Shoushtari, Richard Kinh Gian Do, Marcia Edelweiss, Ali Shamseddine, Walid Faraj, Deborah Mukherji, Ali Haydar, Ashwaq Olayan, Fouad Sabatin, Rita Assi, Imane El Dika, Leonard B. Saltz, Ghassan K. Abou-Alfa, Eileen M. O’Reilly
Journal of Gastrointestinal Oncology  
2017;
8
(3)
:596-602
.

Case Report

The utility of positron emission tomography/computed tomography in target delineation for stereotactic body radiotherapy for liver metastasis from primary gastric cancer: an illustrative case report and literature review
Gary D. Lewis, Stephen B. Chiang, E. Brian Butler, Bin S. Teh
Journal of Gastrointestinal Oncology  
2017;
8
(3)
:E39-E42
.
Neoadjuvant transarterial radiation lobectomy for colorectal hepatic metastases: a small cohort analysis on safety, efficacy, and radiopathologic correlation
Jehan L. Shah, Ivan R. Zendejas-Ruiz, Linday M. Thornton, Brian S. Geller, Joseph R. Grajo, Amy Collinsworth, Thomas J. George Jr, Beau Toskich
Journal of Gastrointestinal Oncology  
2017;
8
(3)
:E43-E51
.

Disclosure:

1. The focused issue “Novel Biologics In Era of Precision Medicine” was commissioned by the Editorial office, Journal of Gastrointestinal Oncology without any sponsorship or funding. Andrea Wang-Gillam and Kian-Huat Lim served as the unpaid Guest Editors for the focused issue.

2. The series “Educational Case Series of the Memorial Sloan Kettering Cancer Center” was commissioned by the Editorial office, Journal of Gastrointestinal Oncology without any sponsorship or funding. Ghassan K. Abou-Alfa served as the unpaid Guest Editor for the series.